HomeAI · summaries
Storia in 3 fonti
Bristol Myers ends deal with Cellares, cell therapy manufacturer to reorg
Bristol Myers exits its Cellares CAR-T manufacturing deal after the Cell Shuttle falls short, prompting a reorg at Cellares.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Cellares, a cell therapy manufacturing specialist, to lay off 100 employees
The restructuring comes after an unnamed "large pharmaceutical customer" terminated a contract with the company, Cellares CEO Fabian Gerlinghaus posted on LinkedIn.
- ·
fiercepharma.com
Cellares CEO seeks to 'resize' company after loss of 'large' cell therapy manufacturing customer
With its ascent seemingly unstoppable in the last few years, automated cell therapy manufacturer Cellares is facing some tough new realities. | With its ascent seemingly…
